about
National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.Inhibition of janus kinase 2 by compound AG490 suppresses the proliferation of MDA-MB-231 cells via up-regulating SARI (suppressor of AP-1, regulated by IFN).Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance).Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational studyPredictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation.CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma.Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy.Rhomboid Flap Technique in Breast-conserving Surgery: An Alternative Method for the Reconstruction of Lumpectomy Defects.Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes.A look at the progress of treating pancreatic cancer over the past 20 years.Does response to neo-adjuvant chemotherapy impact breast reconstruction?Supportive care needs of multicultural patients with cancer in the United Arab Emirates.Comprehensive transcriptomic analysis of heat shock proteins in the molecular subtypes of human breast cancer.
P2860
Q31150366-EAC0B360-520B-4097-823E-FAC1E9390085Q35875900-A4A4E45D-F9DF-40C3-9564-DAFF613475B8Q36455979-5DBF26D4-2022-45CA-98BD-006495E64035Q36577603-26EC2D61-A134-4EB4-B6D8-F950A024287DQ36868191-70A4C37E-20D3-4379-A119-A42069556561Q37016683-299F6856-C6D1-4FFC-9107-9E7B8FC5A0AAQ38964160-F558E014-2B85-4252-9954-F4C747F1DFD7Q39036945-F5C48654-01A0-468C-88A5-E80F481CADC7Q39685538-4A7E266D-CAB4-4B6C-93F1-971CD3F25581Q41483585-624EEF9D-26D0-431C-95C7-861F68C918BDQ41981007-D13503CA-56BE-4D74-AB99-9576C7EF3CB8Q42275833-83B6D5E1-5F79-481D-B9A5-B20FCD42E122Q47731653-6E18EA58-115C-4116-AAB8-7FA933F149D8Q48280810-F704B359-3C8C-4755-B9AD-22AEF7BC0A47Q55282196-E9F21D32-C89E-4850-8247-51704AB61581Q55493581-AA5E66EE-0C4B-47BA-B5F7-E655C696C2B5
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Neoadjuvant therapy in the treatment of breast cancer
@ast
Neoadjuvant therapy in the treatment of breast cancer
@en
Neoadjuvant therapy in the treatment of breast cancer
@nl
type
label
Neoadjuvant therapy in the treatment of breast cancer
@ast
Neoadjuvant therapy in the treatment of breast cancer
@en
Neoadjuvant therapy in the treatment of breast cancer
@nl
prefLabel
Neoadjuvant therapy in the treatment of breast cancer
@ast
Neoadjuvant therapy in the treatment of breast cancer
@en
Neoadjuvant therapy in the treatment of breast cancer
@nl
P2860
P3181
P1476
Neoadjuvant therapy in the treatment of breast cancer
@en
P2093
Kelly K. Hunt
Mediget Teshome
P2860
P304
P3181
P356
10.1016/J.SOC.2014.03.006
P407
P577
2014-07-01T00:00:00Z